Service Outcomes for Germline Test Delivery for Patients With Metastatic Prostate Cancer.

ABSTRACT:

Importance

Germline testing can improve cancer management through use of targeted treatment and risk-specific cancer screening and prevention.

Objective

To compare service outcomes (care that is safe, timely, effective, efficient, equitable, and patient-centered) for germline testing under delivery models with varying involvement of oncologists and genetics clinicians.

Design, setting, and participants

This quality improvement study was performed within the Veterans Health Administration (VHA) from May 3, 2021, to May 2, 2023, with follow-up through November 2, 2023 using mixed methods analysis. Participants included patients with metastatic prostate cancer (mPRCA), germline test orders, and cancer care visits. Key informants included patients, clinicians, and VHA lab

SUBMITTER: Scheuner MT 

PROVIDER: S-EPMC12949434 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature